Found 268 clinical trials
Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine Low Dose TBI PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil
Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA & Mycophenolate Mofetil
- 14 views
- 07 Nov, 2020
- 1 location
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
The study is a Phase II clinical trial. Patients will receive intensity modulated total marrow irradiation (TMI) at a dose of 9 Gy with standard myeloablative fludarabine/ i.v. targeted busulfan
- 6 views
- 11 Jun, 2021
- 1 location
Venetoclax and Sequential Busulfan Cladribine and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
This randomized phase II trial studies how well venetoclax and sequential busulfan, cladribine, and fludarabine phosphate before donor stem cell transplant work in treating patients with acute
- 13 views
- 15 Feb, 2021
- 1 location
Intensity Modulated Total Marrow Irradiation Fludarabine Phosphate and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
This phase I trial studies the side effects and the best dose of intensity modulated total marrow irradiation (IMTMI) when given together with fludarabine phosphate and melphalan in treating
- 13 views
- 27 Jan, 2021
- 1 location
Propylene Glycol-Free Melphalan HCl (EVOMELA ) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
This is an open-label, single-arm, phase II study to determine the safety of propylene glycol-free melphalan HCl (EVOMELA), in combination with fludarabine and total-body irradiation-based
- 7 views
- 02 Jun, 2021
- 1 location
Total Marrow and Lymphoid Irradiation Fludarabine and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
This phase I studies the side effects and best dose of total marrow and lymphoid irradiation when given together with fludarabine and melphalan before donor stem cell transplant in treating
- 17 views
- 19 Feb, 2021
- 1 location
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian Fallopian Tube or Primary Peritoneal Cancer
Phase I study to establish safety and feasibility of intraperitoneally administered lentiviral transduced MOv19-BBz CAR T cells with or without cyclophosphamide + fludarabine as lymphodepleting
- 32 views
- 12 Feb, 2021
- 1 location
Safety Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma
fludarabine and/or cyclophosphamide
- 0 views
- 27 Jan, 2021
- 5 locations
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
consisting of cyclophosphamide and fludarabine.
- 0 views
- 01 May, 2021
- 3 locations
Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.
of Fludarabine + Busulfan + Melphalan as salvage treatment in patients with refractory AML .
- 0 views
- 09 Jun, 2021
- 3 locations